Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
0.5587
-0.0703 (-11.18%)
Jul 20, 2026, 11:29 AM EDT - Market open
Evogene Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1.84 | 3.85 | 5.58 | 2.98 | 1.68 | 0.93 | |
Revenue Growth (YoY) | -70.41% | -30.91% | 87.02% | 78.03% | 80.11% | -10.58% |
Cost of Revenue | 2.71 | 4.09 | 2.38 | 1.49 | 0.91 | 0.77 |
Gross Profit | -0.86 | -0.24 | 3.2 | 1.49 | 0.77 | 0.16 |
Selling, General & Admin | 5.73 | 5.76 | 8.98 | 7.53 | 10.42 | 9.99 |
Research & Development | 7.36 | 7.99 | 12.51 | 16.2 | 20.79 | 21.13 |
Other Operating Expenses | 0.2 | 0.04 | 0.51 | - | -3.5 | - |
Total Operating Expenses | 13.29 | 13.79 | 22 | 23.72 | 27.71 | 31.12 |
Operating Income | -14.16 | -14.03 | -18.8 | -22.23 | -26.94 | -30.95 |
Interest Income | 2.05 | 2.51 | 7.39 | 1.21 | 0.52 | 1.94 |
Interest Expense | -5.32 | -1.93 | -3.36 | -0.93 | -3.33 | -1.41 |
Other Non-Operating Income (Expense) | 0.08 | -0.04 | -0.04 | - | - | - |
Total Non-Operating Income (Expense) | -3.18 | 0.54 | 4 | 0.29 | -2.81 | 0.52 |
Pretax Income | -17.5 | -13.5 | -14.81 | -21.95 | -29.75 | -30.43 |
Provision for Income Taxes | 0.01 | 0 | 0.01 | 0.02 | 0.09 | 0.01 |
Net Income | -17.51 | -13.5 | -14.82 | -21.97 | -29.84 | -30.45 |
Minority Interest in Earnings | 1.03 | 0.66 | -1.57 | -2.08 | -3.21 | -2.65 |
Earnings From Discontinued Operations | -1.15 | 5.67 | -3.24 | -3.99 | - | - |
Net Income to Common | -11.77 | -8.49 | -16.49 | -23.88 | -26.64 | -27.79 |
Shares Outstanding (Basic) | 9 | 8 | 6 | 5 | 4 | 4 |
Shares Outstanding (Diluted) | 9 | 8 | 6 | 5 | 4 | 4 |
Shares Change (YoY) | 40.45% | 38.21% | 24.14% | 10.81% | 2.44% | 43.59% |
EPS (Basic) | -2.02 | -1.08 | -2.90 | -5.20 | -6.44 | -6.90 |
EPS (Diluted) | -2.02 | -1.08 | -2.90 | -5.20 | -6.44 | -6.90 |
Free Cash Flow | -11.29 | -13.64 | -20.33 | -22.15 | -24.85 | -25.56 |
Free Cash Flow Per Share | -1.31 | -1.73 | -3.57 | -4.83 | -6.00 | -6.32 |
Gross Margin | -46.80% | -6.25% | 57.32% | 50.03% | 45.73% | 17.53% |
Operating Margin | -767.73% | -364.24% | -337.17% | -745.51% | -1608.42% | -3328.28% |
Profit Margin | -949.35% | -350.35% | -265.68% | -736.59% | -1781.73% | -3273.66% |
FCF Margin | -612.26% | -353.93% | -364.46% | -742.92% | -1483.52% | -2748.71% |
EBITDA | -13.12 | -12.89 | -17.42 | -20.93 | -24.36 | -28.72 |
EBITDA Margin | -711.55% | -334.55% | -312.41% | -701.91% | -1454.39% | -3088.06% |
EBIT | -14.16 | -14.03 | -18.8 | -22.23 | -26.94 | -30.95 |
EBIT Margin | -767.73% | -364.24% | -337.17% | -745.51% | -1608.42% | -3328.28% |
Effective Tax Rate | -0.03% | -0.01% | -0.06% | -0.09% | -0.30% | -0.04% |